Pharmaceuticals Report: Switzerland

Clinical Professionals and Vacancysoft

February 2017

Key trends emerging include:

  • The release of EU’s proposals to amend the Medical Device and the In Vitro Diagnostic Regulations coincided with a spike in new vacancies.
  • Growth came from companies with more than 5,000 staff and those with no more than 500 staff.
  • Traditional pharma companies have showed a slight upwards trend over the last two years but CROs and biotech firms have had almost flat, very slightly downwards trends in those years.

Yes, I want this report!


    Yes, I would like to receive more information about your products, offers, and events. I understand I can unsubscribe at any time.*

    When you provide the information above, we will use it to process your request as described in our Privacy Policy .

    February is usually the best month of the year to visit Switzerland (for skiers anyway). And it’s also the month we release the annual report we co-produce with Clinical Professionals about recruitment in the Pharmaceuticals sector in Switzerland. While the overall growth in the number of vacancies there was not hugely impressive, at 6.7% year on year, compared to certain sectors in a certain Brexit-affected nation we won’t name here and their double-digit falls, it’s a very sound result. And of course there were places in Switzerland and parts of the Swiss Pharmaceuticals sector which saw growth much higher than the overall national average.

    Vacancysoft is the Data Publisher for the Recruitment Industry. We provide recruiters with daily lead lists that help to monitor their clients’ hiring and to identify companies struggling to hire.

    Related Posts

    Midlands — UK Regional Labour Market Trends, June ... As the largest regional economy in the UK, what recruitment trends have we seen in the Midlands so far in 2022? Which sectors saw the most growth, and...
    Engineering vacancies set to reach record high due... Need for innovation in life sciences means engineering vacancies in Europe are likely to hit record levels in 2022 Pharmaceuticals have the lion’s sh...